< Back to Newsletter Archive

BIO Newsletter
BIO Newsletter: BIO Statement on National Academies' Consensus Study, Another Successful BIO CEO & Investor Conference
SUBSCRIBE | VIEW ONLINE 02.23.2017
BIO NEWSLETTER
Providing Critical Information About the Industry
VISIT BIO.ORG
BIO Statement on National Academies' Consensus Study on Human Gene Editing
“We appreciate that the National Academies of Medicine and Science have taken the time to carefully review this cutting edge area of medicine. Independent, professional review has helped inform the legal, ethical, and regulatory aspects of recombinant DNA technology since the 1970s. For the past 40 years, with help from the scientific community, the United States has continuously added to a biomedical R&D framework of laws, regulations, and guidelines to keep pace with advances in genomics"
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO CEO & Investor Conference
BIO CEO & Investor Conference
spacer
BIO CEO & Investor Conference Succeeds in Bringing Innovators to Investors and
Vice Versaarrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO Asia International Conference
spacer
Register for the BIO Asia International
Conferencearrow

SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO Asia International Conference
Double border
HEALTH HEALTH
ICYMI: How Other Countries Freeload on U.S. Drug Research -WSJ
Writing for the Wall Street Journal this week, former FDA Associate Commissioner Peter Pitts has a timely reminder on why allowing the importation of overseas drugs in an effort to save money – despite being proposed for decades– remains a bad idea that would produce scant savings while hampering continued innovation and investment…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY
Nominations Now Open for the BIO George Washington Carver Award for Innovation in Industrial Biotechnology
The ninth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally sustainable products…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
I&E INDUSTRIAL & ENVIRONMENTAL
BIO Submits Comments on EPA Renewables Enhancement and Growth Support Rule
BIO submitted comments on the Environmental Protection Agency’s recently proposed Renewables Enhancement and Growth Support Rule. BIO supports EPA’s ongoing efforts to improve the efficiency and effectiveness of the federal Renewable Fuel Standard…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
EU’s Anti-Science Comitology Reform Threatens Innovation
The European Commission announced a proposal to revise its Comitology Regulation forcing policy decisions to individual EU member countries…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
Biopharma Takes Aim at Opioid Abuse
Next-generation painkillers in development are non-addictive. One in three Americans – roughly 100 million people – report suffering from some type of pain, according to the National Academy of Science’s Institute of Medicine. That’s more people than suffer from diabetes, cancer and heart disease combined…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Foog and Ag FOOD & AGRICULTURE
GM Hens Could Save an Entire Species
"Researchers at the Roslin Institute have genetically modified chickens who act as surrogates to lay the eggs of rare chicken species,” Futurism recently reported. “The success of this study could help scientists to save endangered species and prevent the depletion of species used as food sources."
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Bio Jobs
Bio Jobs
©2017 Biotechnology Innovation Organization. All rights reserved.
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising
FOLLOW US: Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Email us